Tay-Sachs and Sandhoff diseases, genetic disorders affecting the brain, have no effective treatment and are typically fatal ...

Proceeding with hematopoietic stem cell transplantation (HSCT) is more cost-effective than delaying the procedure in patients ...

Hematopoietic cell transplant (HCT) is a potentially curative treatment for hematologic malignancies, autoimmune disorders, and blood dyscrasias. 1 Hematopoietic stem cells can be collected from ...

BMT-CARE app boosted quality of life, lowered depression and PTSD symptoms, and improved coping mechanisms for caregivers of ...

Allogeneic hematopoietic cell transplantation (allo-HCT) is feasible in older patients with myelodysplastic syndrome (MDS), ...

NMDP SM, a global nonprofit leader in cell therapy, and its collaborative research program, CIBMTR® (Center for International Blood and Marrow Transplant Research®), announced today that the first ...

Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative therapy for many advanced hematologic malignancies and bone marrow failure or immunodeficiency syndromes. Allogeneic HCT, ...

Pharmacologic suppression of graft-versus-host disease (GVHD) is critical to the success of hematopoietic stem cell transplantation (HSCT). 1 The use of cyclophosphamide for GVHD prevention has ...

Post-transplantation cyclophosphamide (PTCy) led to similar overall survival (OS) and graft-versus-host disease (GVHD)-free relapse-free survival (GRFS) in patients who received a hematopoietic stem ...

These findings were based on data from the Center for International Blood and Marrow Transplant Research, a national stem cell transplant registry, which was used by the researchers to compare data ...